Loading...
UK Trademark — IPO
MedXcell
Application UK00801488241 · Registered
Quick Facts
| Application Number | UK00801488241 |
| Status | Registered |
| Owner | MedXCell SA |
| Filed | 2019-06-07 |
| Registered | 2020-03-04 |
| Renewal Due | 2029-06-07 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. MedXcell is currently a registered UK trademark, with renewal due on 2029-06-07. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Pharmaceutical preparations for cell therapy treatment of joint and vertebral trauma; pharmaceutical products for treatment of joint and vertebral trauma; cultures of micro-organisms for medical use; biological tissue cultures for medical use; surgical implants grown from stem cells; surgical implants composed of living tissue; stem cells for cell therapy; biological cell-derived products.
Timeline
- Filed: 2019-06-07
- Registered: 2020-03-04
- Renewal due: 2029-06-07
About This Trademark
'MedXcell' is a registered trademark on the UK IPO register, owned by MedXCell SA. The application (UK00801488241) was filed on 7 June 2019 and registered on 4 March 2020. The registration is set to expire on 7 June 2029.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Katzarov SA.
Frequently Asked Questions
Who owns UK trademark UK00801488241 ('MedXcell')?
UK trademark UK00801488241 for the mark 'MedXcell' in Class 5 is recorded on the UK IPO register as owned by MedXCell SA. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00801488241 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00801488241 for the mark 'MedXcell' as registered.
Which goods or services does UK trademark UK00801488241 cover?
UK trademark UK00801488241 for the mark 'MedXcell' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations for cell therapy treatment of joint and vertebral trauma; pharmaceutical products for treatment of joint and vertebral trauma; cultures of micro-organisms for medical use; biological tissue cultures for medical use; surgical implants grown from stem cells; surgical implants compo…
When was UK trademark UK00801488241 filed?
UK trademark UK00801488241 for the mark 'MedXcell' was filed at the UK IPO on 7 June 2019 and registered on 4 March 2020.
When does UK trademark UK00801488241 need to be renewed?
UK trademark UK00801488241 for the mark 'MedXcell' is currently recorded as valid until 7 June 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00801488241?
Katzarov SA is listed as the attorney / representative of record for UK trademark UK00801488241 for the mark 'MedXcell' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.